Skip to main content
Top

Current Oncology Reports

Issue 11/2023

Content (15 Articles)

New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors

Jung H. Yun, Adam Fang, Fereshteh Khorshidi, Peiman Habibollahi, Oleksandra Kutsenko, Vahid Etezadi, Stephen Hunt, Nariman Nezami

Open Access Breast Cancer

Exercise as Medicine in Cardio-Oncology: Reducing Health Disparities in Hispanic and Latina Breast Cancer Survivors

Paola Gonzalo-Encabo, Nathalie Sami, Rebekah L. Wilson, Dong-Woo Kang, Salvatore Ficarra, Christina M. Dieli-Conwright

Open Access Mucosal Melanoma

Mucosal Melanoma: Epidemiology, Clinical Features, and Treatment

Maria Chiara Sergi, Elisabetta Filoni, Giacomo Triggiano, Gerardo Cazzato, Valeria Internò, Camillo Porta, Marco Tucci

Immune-Related Adverse Events in Patients with Lung Cancer

Guilherme Sacchi de Camargo Correia, Tanmayi Pai, Shenduo Li, Dana Connor, Yujie Zhao, Yanyan Lou, Rami Manochakian

Open Access SCLC

Novel Therapeutic Options for Small Cell Lung Cancer

Stefania Canova, Benedetta Trevisan, Maria Ida Abbate, Francesca Colonese, Luca Sala, Alice Baggi, Sofia Paola Bianchi, Anna D’Agostino, Diego Luigi Cortinovis

Incorporation of Palliative Care in Gynecologic Oncology

Christianne Persenaire, Daniel L. Spinosa, Lindsay W. Brubaker, Carolyn J. Lefkowits

Open Access Lymphadenectomy

Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and Future Perspectives

Andrzej Dłubak, Jakub Karwacki, Katarzyna Logoń, Paulina Tomecka, Kinga Brawańska, Wojciech Krajewski, Tomasz Szydełko, Bartosz Małkiewicz

Open Access Expert Opinion

Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts

Daniele Santini, Giuseppe Luigi Banna, Sebastiano Buti, Luca Isella, Marco Stellato, Michela Roberto, Roberto Iacovelli

Open Access Prostate Cancer

Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer—Combination Strategies

Daria Arbuznikova, Matthias Eder, Anca-Ligia Grosu, Philipp T. Meyer, Christian Gratzke, Constantinos Zamboglou, Ann-Christin Eder

What Is New in Cutaneous T Cell Lymphoma?

Sarah Morgenroth, Andrea Roggo, Laura Pawlik, Reinhard Dummer, Egle Ramelyte

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine